Podcast, The Genetics Podcast, Episode 261
Inside the virtual biotech staffed by AI agents with James Zou of Stanford University
About
James Zou, associate professor of biomedical data science at Stanford University, describes a virtual biotech staffed by collaborating AI scientist agents that link single-cell evidence behind drug targets to clinical-trial success, how autonomous those agents are, and why missing proprietary trial data is the next gap. He discusses scaling the number of collaborating agents and how teamwork and structure emerged among them, Paper to Agent, which turns published papers into interactive virtual authors and has exposed reproducibility problems across more than 100 papers, and clinical AI from the FDA-cleared EchoNet cardiac-ultrasound tool to SleepFM, which predicts risk of more than 100 diseases from one night of sleep.